Chemours (CC) Competitors $17.72 +0.25 (+1.43%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CC vs. AXTA, CSWI, ICL, ESI, ALTM, MEOH, PCT, PRM, BAK, and NGVTShould you be buying Chemours stock or one of its competitors? The main competitors of Chemours include Axalta Coating Systems (AXTA), CSW Industrials (CSWI), ICL Group (ICL), Element Solutions (ESI), Arcadium Lithium (ALTM), Methanex (MEOH), PureCycle Technologies (PCT), Perimeter Solutions (PRM), Braskem (BAK), and Ingevity (NGVT). These companies are all part of the "chemicals" industry. Chemours vs. Axalta Coating Systems CSW Industrials ICL Group Element Solutions Arcadium Lithium Methanex PureCycle Technologies Perimeter Solutions Braskem Ingevity Axalta Coating Systems (NYSE:AXTA) and Chemours (NYSE:CC) are both mid-cap basic materials companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, media sentiment, earnings, community ranking, institutional ownership, risk, profitability and valuation. Which has more volatility and risk, AXTA or CC? Axalta Coating Systems has a beta of 1.44, meaning that its stock price is 44% more volatile than the S&P 500. Comparatively, Chemours has a beta of 1.8, meaning that its stock price is 80% more volatile than the S&P 500. Does the MarketBeat Community favor AXTA or CC? Chemours received 110 more outperform votes than Axalta Coating Systems when rated by MarketBeat users. However, 63.47% of users gave Axalta Coating Systems an outperform vote while only 60.87% of users gave Chemours an outperform vote. CompanyUnderperformOutperformAxalta Coating SystemsOutperform Votes52363.47% Underperform Votes30136.53% ChemoursOutperform Votes63360.87% Underperform Votes40739.13% Do institutionals and insiders believe in AXTA or CC? 98.3% of Axalta Coating Systems shares are owned by institutional investors. Comparatively, 76.3% of Chemours shares are owned by institutional investors. 0.4% of Axalta Coating Systems shares are owned by insiders. Comparatively, 0.5% of Chemours shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is AXTA or CC more profitable? Axalta Coating Systems has a net margin of 6.22% compared to Chemours' net margin of 1.34%. Chemours' return on equity of 29.48% beat Axalta Coating Systems' return on equity.Company Net Margins Return on Equity Return on Assets Axalta Coating Systems6.22% 24.92% 6.25% Chemours 1.34%29.48%2.74% Do analysts rate AXTA or CC? Axalta Coating Systems currently has a consensus price target of $42.50, indicating a potential upside of 23.55%. Chemours has a consensus price target of $24.88, indicating a potential upside of 40.38%. Given Chemours' higher probable upside, analysts plainly believe Chemours is more favorable than Axalta Coating Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Axalta Coating Systems 0 Sell rating(s) 4 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 2.85Chemours 0 Sell rating(s) 5 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.38 Does the media prefer AXTA or CC? In the previous week, Axalta Coating Systems had 21 more articles in the media than Chemours. MarketBeat recorded 23 mentions for Axalta Coating Systems and 2 mentions for Chemours. Axalta Coating Systems' average media sentiment score of 0.25 beat Chemours' score of 0.25 indicating that Axalta Coating Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Axalta Coating Systems 5 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Neutral Chemours 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has better valuation & earnings, AXTA or CC? Axalta Coating Systems has higher earnings, but lower revenue than Chemours. Axalta Coating Systems is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAxalta Coating Systems$5.26B1.43$267.40M$1.4823.24Chemours$5.75B0.46-$238M$0.5035.44 SummaryAxalta Coating Systems beats Chemours on 12 of the 19 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Get Chemours News Delivered to You Automatically Sign up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CC vs. The Competition Export to ExcelMetricChemoursChemicals & allied products IndustryMaterials SectorNYSE ExchangeMarket Cap$2.65B$5.01B$2.83B$19.18BDividend Yield5.76%2.81%5.15%3.60%P/E Ratio35.4418.05111.7941.30Price / Sales0.4654.33792,415.3417.60Price / Cash3.8911.1224.2721.28Price / Book3.563.463.395.32Net Income-$238M$232.63M$154.11M$989.88M7 Day Performance-6.93%-4.96%-2.89%-3.54%1 Month Performance-14.91%-4.37%1.41%-3.68%1 Year Performance-42.97%1.64%17.82%12.14% Chemours Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CCChemours4.1163 of 5 stars$17.72+1.4%$24.88+40.4%-41.5%$2.65B$5.75B35.446,200High Trading VolumeAXTAAxalta Coating Systems4.5616 of 5 stars$37.80-1.1%$42.45+12.3%+2.7%$8.24B$5.18B25.8312,000Analyst ForecastAnalyst RevisionNews CoveragePositive NewsCSWICSW Industrials4.6177 of 5 stars$390.58+0.5%$437.50+12.0%+76.4%$6.57B$839.93M53.152,600Analyst ForecastGap DownICLICL Group2.1135 of 5 stars$4.95-2.9%$4.00-19.2%-1.6%$6.50B$6.93B15.9713,350Positive NewsESIElement Solutions4.4412 of 5 stars$26.77-1.9%$31.40+17.3%+11.6%$6.48B$2.33B24.595,300Positive NewsALTMArcadium Lithium3.1321 of 5 stars$5.12-0.4%$11.00+114.8%N/A$5.51B$1.21B19.001,470News CoverageMEOHMethanex4.2198 of 5 stars$46.25+1.2%$57.25+23.8%-3.0%$3.12B$3.69B21.361,451Ex-DividendPositive NewsPCTPureCycle Technologies1.1771 of 5 stars$12.04+2.5%$10.60-12.0%+194.8%$2.09BN/A-7.83146PRMPerimeter Solutions2.3354 of 5 stars$12.99+1.3%$14.50+11.6%+197.2%$1.90B$322.11M0.00240Positive NewsBAKBraskem2.3955 of 5 stars$4.19-1.9%$9.75+132.7%-50.2%$1.89B$74.95B-1.208,310NGVTIngevity3.7688 of 5 stars$45.67-0.3%$52.17+14.2%-10.3%$1.66B$1.48B-2.931,700 Related Companies and Tools Related Companies AXTA Alternatives CSWI Alternatives ICL Alternatives ESI Alternatives ALTM Alternatives MEOH Alternatives PCT Alternatives PRM Alternatives BAK Alternatives NGVT Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:CC) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Chemours Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Chemours With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
